top of page
CEDAR is a multi-centre, single arm, open label, post-market registry study to assess the clinical outcomes of the Castor™ Branched Aortic Stent Graft System in an all-comer, real world patient population.
Involving global investigational sites across EMEA and LATAM with experience in the Castor™, and eligible patient enrolment at each, data on patients undergoing TEVAR with the device will be collected in this large open-ended registry.
bottom of page